Chronic heart failure: An updated programme for diagnosis and treatment;Kronisk hjertesvikt - Forslag til handlingsprogram

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 23, 1999, Pages 3427-3431

  Westheim, Arne ^a   Dickstein, Kenneth ^b   Gundersen, Torstein ^b   Hole, Torstein ^b   Kjekshus, John ^b   Myhre, Eivind S P ^b   Rønnevik, Per K ^b   Samstad, Stein ^b   Smith, Pal ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE; CAPTOPRIL; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOSARTAN; METOPROLOL; SIMVASTATIN; SPIRONOLACTONE;

CLINICAL TRIAL; DRUG CONTRAINDICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORGANIZATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; SHORT SURVEY; THORAX RADIOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; DIGITALIS GLYCOSIDES; DIURETICS; GUIDELINES; HEART FAILURE, CONGESTIVE; HUMANS; NORWAY; REGIONAL MEDICAL PROGRAMS; SOCIETIES, MEDICAL; VASODILATOR AGENTS;

EID: 0033619252     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. Westheim A, Dickstein K, Gundersen T, Hole T, Myhre ESP, Rønnevik PK et al. Kronisk hjertesvikt. Handlingsprogram. Forslag til undersøkelser og behandling. Tidsskr Nor Lægeforen 1994; 114; 1424-7.
2. CIBIS Investigators and Committees. A randomised trial of beta blockade in heart failure: the Cardiac Insufficency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765-73.
3. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al. for the Carvedilol Heart Failure Study Group. The effects of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
4. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controiled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997; 349: 375-80.
5. Packer M, O'Connor CM, Ghali J, Pressler ML, Carson P, Belkin RN et al for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of Amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-14.
6. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
7. Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lungborg K et al for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 33: 1670-6.
8. Dickstein K, Larsen AI, Bonarjee V, Thoresen M, Aarsland T, Hall C. Pro-atrial natriuretisk faktor i plasma er prediktiv for klinisk status hos hjertesviktpasienter. Tidsskr Nor Lægeforen 1996; 116: 1562-6.
9. Omland T. Måting av natriuretiske peptider ved kronisk venstre ventrikkeldysfunksjon: hva er den diagnostiske verdi. Hjerteforum 1997; 10: 5-23.
10. Statens legemiddelkontroll. Behandling av akutt og kronisk hjertesvikt. Nytt om Legemidler 1996; (suppl 6): 3-7.
11. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997; 18: 736-53.
12. ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995; 26: 1376-98.
13. McKee PA, Castelli WP, McNamara PM, Kannel WP. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-6.
14. Sutton GCS. Epidemiologic aspects of heart failure. Am Heart J 1990; 120: 1538-40.
15. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-6.
16. Wheeldon MM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DC, Struthers AD. Echocardiography in chronic heart failure in the community. Quart J Med 1993; 86: 17-23.
17. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22 (suppl A): 6-13.
18. Klemsdal TO, Mangschau A. Hjertesvikt i norske sykehusavdelinger. Tidsskr Nor Lægeforen 1994; 114: 2473-6.
19. McMurray J, McDonald T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-92. Eur Heart J 1993; 14: 1158-62.
20. Garg R, Yusuf S. Epidemiology of congestive heart failure. I: Barnett DB, Poleur H, Francis GS, red. Congestive cardiac failure - pathophysiology and treatment. New York: Marcel Dekker, 1993: 9-25.
21. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
22. Packer M, Poole-Wilson P, Armstrong P, Cleland J, Horowitz J, Massie B et al. Comparative effects of low-dose versus high-dose lisinopril on survival and major events in chronic heart fail-ore: the Assesment of Treatment with Lisinopril And Survival study (ATLAS). Eur Heart J 1998; 19 (abstract suppl): 142.
23. Ljungman S, Kjekshus J, Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril (the cooperative north Scandinavian enalapril survival study (CONSENSUS) trial). Am J Cardiol 1992; 70: 479-87.
24. Gundersen T, Dickstein K, Hole T, Kjekshus J, Myhre ESP, Rønnevik P et al. Betablokkerbehandling av hjertesviktpasienter. Tidsskr Nor Lægeforen 1997; 117: 526-8.
25. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
26. Pitt B, Segal R, Martinez FA, Meureres O, Cowley AJ, Thomas I et al on behalf of ELITE Study investigators. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747-52.
27. Myhre ESP, Gundersen T, Dickstein K, Hole T, Kjekshus J, Rønnevik P et al. Kronisk venstre ventrikkel-svikt og inotrop stimulering. Tidsskr Nor Lægeforen 1995; 115: 360-4.
28. Singh SN, Fletcher RD, Gross SF, Singh BN, Lewis HD, Deedwania PC et al for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
29. Kjekshus J, Pedersen T, for the Scandinavian Simvastatin Survival Study Group. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 1995; 76: 64-8.
30. Balk AHMM. The «heart failure nurse» to help us close the gap between what we can and what we do achieve. Eur Heart J 1999; 20: 632-3.